AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
PEMBROLIZUMAB in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| KEYTRUDA Concentrate for solution for infusion | RWANDA-FDA24/HM/0443/0070 | BOEHRINGER INGELHEIM PHARMA GmbH & Co. KG. | active | 7 May 2031 |
PEMBROLIZUMAB — RDA Registration Details
RDA (Rwanda) has 1 registered product containing PEMBROLIZUMAB, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track PEMBROLIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.